Executive Director, Respiratory
Leads translational biology strategy in respiratory research, integrating human-centric science to drive target validation and clinical translation across diseases like COPD, IPF, and pulmonary hypertension. Builds and leads a multidisciplinary team, leveraging internal and external capabilities to advance GSK's respiratory portfolio with a focus on mechanistic insight and biomarker integration.